Literature DB >> 20663884

Analysis of CD44-hyaluronan interactions in an artificial membrane system: insights into the distinct binding properties of high and low molecular weight hyaluronan.

Patricia M Wolny1, Suneale Banerji, Céline Gounou, Alain R Brisson, Anthony J Day, David G Jackson, Ralf P Richter.   

Abstract

CD44 is a major cell surface receptor for the large polydisperse glycosaminoglycan hyaluronan (HA). Binding of the long and flexible HA chains is thought to be stabilized by the multivalent nature of the sugar molecule. In addition, high and low molecular weight forms of HA provoke distinct proinflammatory and anti-inflammatory effects upon binding to CD44 and can deliver either proliferative or antiproliferative signals in appropriate cell types. Despite the importance of such interactions, however, neither the stoichiometry of multivalent HA binding at the cell surface nor the molecular basis for functional distinction between different HA size categories is understood. Here we report on the design of a supported lipid bilayer system that permits quantitative analysis of multivalent binding through presentation of CD44 in a stable, natively oriented manner and at controlled density. Using this system in combination with biophysical techniques, we show that the amount of HA binding to bilayers that are densely coated with CD44 increases as a function of HA size, with half-maximal saturation at ∼30 kDa. Moreover, reversible binding was confined to the smaller HA species (molecular weight of ≤10 kDa), whereas the interaction was essentially irreversible with larger polymers. The amount of bound HA decreased with decreasing receptor surface density, but the stability of binding was not affected. From a physico-chemical perspective, the binding properties of HA share many similarities with the typical behavior of a flexible polymer as it adsorbs onto a homogeneously attractive surface. These findings provide new insight into the multivalent nature of CD44-HA interactions and suggest a molecular basis for the distinct biological properties of different size fractions of hyaluronan.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20663884      PMCID: PMC2943326          DOI: 10.1074/jbc.M110.137562

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  55 in total

1.  The role of the CD44 cytoplasmic and transmembrane domains in constitutive and inducible hyaluronan binding.

Authors:  J Lesley; N English; C Charles; R Hyman
Journal:  Eur J Immunol       Date:  2000-01       Impact factor: 5.532

Review 2.  Lecticans: organizers of the brain extracellular matrix.

Authors:  Y Yamaguchi
Journal:  Cell Mol Life Sci       Date:  2000-02       Impact factor: 9.261

3.  Formation of hyaluronan- and versican-rich pericellular matrix is required for proliferation and migration of vascular smooth muscle cells.

Authors:  S P Evanko; J C Angello; T N Wight
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-04       Impact factor: 8.311

4.  Hyaluronan: is bigger better?

Authors:  T D Camenisch; J A McDonald
Journal:  Am J Respir Cell Mol Biol       Date:  2000-10       Impact factor: 6.914

Review 5.  A crucial role for CD44 in inflammation.

Authors:  E Puré; C A Cuff
Journal:  Trends Mol Med       Date:  2001-05       Impact factor: 11.951

6.  Novel methods for the preparation and characterization of hyaluronan oligosaccharides of defined length.

Authors:  D J Mahoney; R T Aplin; A Calabro; V C Hascall; A J Day
Journal:  Glycobiology       Date:  2001-12       Impact factor: 4.313

7.  Hyaluronan binding by cell surface CD44.

Authors:  J Lesley; V C Hascall; M Tammi; R Hyman
Journal:  J Biol Chem       Date:  2000-09-01       Impact factor: 5.157

Review 8.  Hyaluronan: polysaccharide chaos to protein organisation.

Authors:  A J Day; J K Sheehan
Journal:  Curr Opin Struct Biol       Date:  2001-10       Impact factor: 6.809

9.  The analysis of intermolecular interactions in concentrated hyaluronan solutions suggest no evidence for chain-chain association.

Authors:  P Gribbon; B C Heng; T E Hardingham
Journal:  Biochem J       Date:  2000-08-15       Impact factor: 3.857

10.  Regulation of Toll-like receptors in human monocytes and dendritic cells.

Authors:  A Visintin; A Mazzoni; J H Spitzer; D H Wyllie; S K Dower; D M Segal
Journal:  J Immunol       Date:  2001-01-01       Impact factor: 5.422

View more
  80 in total

1.  Tunable CD44-specific cellular retargeting with hyaluronic acid nanoshells.

Authors:  Morten F Ebbesen; Morten Tj Olesen; Mikkel C Gjelstrup; Malgorzata M Pakula; Esben Ku Larsen; Irene M Hansen; Pernille L Hansen; Jan Mollenhauer; Birgitte M Malle; Kenneth A Howard
Journal:  Pharm Res       Date:  2014-11-01       Impact factor: 4.200

2.  Development of multifunctional hyaluronan-coated nanoparticles for imaging and drug delivery to cancer cells.

Authors:  Mohammad H El-Dakdouki; David C Zhu; Kheireddine El-Boubbou; Medha Kamat; Jianjun Chen; Wei Li; Xuefei Huang
Journal:  Biomacromolecules       Date:  2012-03-13       Impact factor: 6.988

3.  Increased Hyaluronan and TSG-6 in Association with Neuropathologic Changes of Alzheimer's Disease.

Authors:  May J Reed; Mamatha Damodarasamy; Jasmine L Pathan; Christina K Chan; Charles Spiekerman; Thomas N Wight; William A Banks; Anthony J Day; Robert B Vernon; C Dirk Keene
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

Review 4.  Hyaluronan in immune dysregulation and autoimmune diseases.

Authors:  Nadine Nagy; Hedwich F Kuipers; Payton L Marshall; Esther Wang; Gernot Kaber; Paul L Bollyky
Journal:  Matrix Biol       Date:  2018-04-04       Impact factor: 11.583

5.  Exposure to polymers reverses inhibition of pulmonary surfactant by serum, meconium, or cholesterol in the captive bubble surfactometer.

Authors:  Elena López-Rodríguez; Olga Lucía Ospina; Mercedes Echaide; H William Taeusch; Jesús Pérez-Gil
Journal:  Biophys J       Date:  2012-10-02       Impact factor: 4.033

Review 6.  The role of hyaluronan and the extracellular matrix in islet inflammation and immune regulation.

Authors:  Paul L Bollyky; Marika Bogdani; Jennifer B Bollyky; Rebecca L Hull; Thomas N Wight
Journal:  Curr Diab Rep       Date:  2012-10       Impact factor: 4.810

7.  Hyaluronic acid-based nanogel-drug conjugates with enhanced anticancer activity designed for the targeting of CD44-positive and drug-resistant tumors.

Authors:  Xin Wei; Thulani H Senanayake; Galya Warren; Serguei V Vinogradov
Journal:  Bioconjug Chem       Date:  2013-04-02       Impact factor: 4.774

8.  Anti-Inflammatory Effects of Intra-Articular Hyaluronic Acid: A Systematic Review.

Authors:  Roy Altman; Asheesh Bedi; Ajay Manjoo; Faizan Niazi; Peter Shaw; Philip Mease
Journal:  Cartilage       Date:  2018-02-11       Impact factor: 4.634

Review 9.  The liver fibrosis niche: Novel insights into the interplay between fibrosis-composing mesenchymal cells, immune cells, endothelial cells, and extracellular matrix.

Authors:  Michitaka Matsuda; Ekihiro Seki
Journal:  Food Chem Toxicol       Date:  2020-07-05       Impact factor: 6.023

10.  Surface Tethering of Inflammation-Modulatory Nanostimulators to Stem Cells for Ischemic Muscle Repair.

Authors:  Jiayu Leong; Yu-Tong Hong; Yu-Fu Wu; Eunkyung Ko; Svyatoslav Dvoretskiy; Jye Yng Teo; Byoung Soo Kim; Kyeongsoo Kim; Hojeong Jeon; Marni Boppart; Yi Yan Yang; Hyunjoon Kong
Journal:  ACS Nano       Date:  2020-04-13       Impact factor: 15.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.